Literature DB >> 16261618

Compulsive eating and weight gain related to dopamine agonist use.

Melissa J Nirenberg1, Cheryl Waters.   

Abstract

Dopamine agonists have been implicated in causing compulsive behaviors in patients with Parkinson's disease (PD). These have included gambling, hypersexuality, hobbyism, and other repetitive, purposeless behaviors ("punding"). In this report, we describe 7 patients in whom compulsive eating developed in the context of pramipexole use. All of the affected patients had significant, undesired weight gain; 4 had other comorbid compulsive behaviors. In the 5 patients who lowered the dose of pramipexole or discontinued dopamine agonist treatment, the behavior remitted and no further weight gain occurred. Physicians should be aware that compulsive eating resulting in significant weight gain may occur in PD as a side-effect of dopamine agonist medications such as pramipexole. Given the known risks of the associated weight gain and obesity, further investigation is warranted. Copyright 2005 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16261618     DOI: 10.1002/mds.20757

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  66 in total

1.  Pramipexole and compulsive masturbation.

Authors:  Randy A Sansone; Mark Ferlan
Journal:  Psychiatry (Edgmont)       Date:  2007-09

2.  Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort.

Authors:  Maren C Locke; Samuel S Wu; Kelly D Foote; Marco Sassi; Charles E Jacobson; Ramon L Rodriguez; Hubert H Fernandez; Michael S Okun
Journal:  Neurosurgery       Date:  2011-05       Impact factor: 4.654

3.  Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.

Authors:  Hengyi Rao; Eugenia Mamikonyan; John A Detre; Andrew D Siderowf; Matthew B Stern; Marc N Potenza; Daniel Weintraub
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

Review 4.  Gut dysfunction in Parkinson's disease.

Authors:  Adreesh Mukherjee; Atanu Biswas; Shyamal Kumar Das
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

5.  Effects of acute pramipexole on male rats' preference for gambling-like rewards II.

Authors:  Patrick S Johnson; Gregory J Madden; Jeffrey S Stein
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-30       Impact factor: 3.157

Review 6.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

7.  Long-term follow-up of impulse control disorders in Parkinson's disease.

Authors:  Eugenia Mamikonyan; Andrew D Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

8.  Sleep and impulsivity in Parkinson's disease.

Authors:  Michael K Scullin; Ann B Sollinger; Julia Land; Cathy Wood-Siverio; Lavezza Zanders; Raven Lee; Alan Freeman; Felicia C Goldstein; Donald L Bliwise; Stewart A Factor
Journal:  Parkinsonism Relat Disord       Date:  2013-07-21       Impact factor: 4.891

Review 9.  Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

Authors:  Sean S O'Sullivan; Andrew H Evans; Andrew J Lees
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior.

Authors:  Chiara Schepisi; Lorenza De Carolis; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.